78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Di Meco A, Jelinek J, Lauretti E, Curtis ME, Issa JJ, Praticό D. Gestational high fat diet protects 3xTg offspring from memory impairments, synaptic dysfunction, and brain pathology. Molecular Psychiatry. PMID 31451749 DOI: 10.1038/s41380-019-0489-y  0.72
2019 Chung W, Kelly AD, Kropf P, Fung H, Jelinek J, Su XY, Roboz GJ, Kantarjian HM, Azab M, Issa JJ. Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia. Clinical Epigenetics. 11: 106. PMID 31331399 DOI: 10.1186/s13148-019-0704-3  0.72
2019 Majewski T, Yao H, Bondaruk J, Chung W, Lee S, Lee JG, Zhang S, Cogdell D, Yang G, Choi W, Dinney C, Grossman HB, Logothetis C, Scherer SE, Guo CC, ... ... Issa JP, et al. Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis. Cell Reports. 26: 2241-2256.e4. PMID 30784602 DOI: 10.1016/j.celrep.2019.01.095  0.32
2019 Tao Y, Kang B, Petkovich DA, Bhandari YR, In J, Stein-O'Brien G, Kong X, Xie W, Zachos N, Maegawa S, Vaidya H, Brown S, Chiu Yen RW, Shao X, Thakor J, ... ... Issa JP, et al. Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and Braf-Induced Tumorigenesis. Cancer Cell. 35: 315-328.e6. PMID 30753828 DOI: 10.1016/j.ccell.2019.01.005  0.56
2018 Zhang H, Pandey S, Travers M, Sun H, Morton G, Madzo J, Chung W, Khowsathit J, Perez-Leal O, Barrero CA, Merali C, Okamoto Y, Sato T, Pan J, Garriga J, ... ... Issa JJ, et al. Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer. Cell. 175: 1244-1258.e26. PMID 30454645 DOI: 10.1016/j.cell.2018.09.051  0.72
2018 Good CR, Panjarian S, Kelly AD, Madzo J, Patel B, Jelinek J, Issa JJ. TET1-mediated hypomethylation activates oncogenic signaling in triple-negative breast cancer. Cancer Research. PMID 29891505 DOI: 10.1158/0008-5472.CAN-17-2082  0.72
2018 Garriga J, Laumet G, Chen SR, Zhang Y, Madzo J, Issa JJ, Pan HL, Jelinek J. Nerve injury-induced chronic pain is associated with persistent DNA methylation reprogramming in dorsal root ganglion. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29875269 DOI: 10.1523/JNEUROSCI.2616-17.2018  0.72
2018 Kelly AD, Madzo J, Madireddi P, Kropf P, Good CR, Jelinek J, Issa JJ. Demethylator phenotypes in acute myeloid leukemia. Leukemia. PMID 29556023 DOI: 10.1038/s41375-018-0084-2  0.72
2018 Jelinek J, Lee JT, Cesaroni M, Madzo J, Liang S, Lu Y, Issa JJ. Digital Restriction Enzyme Analysis of Methylation (DREAM). Methods in Molecular Biology (Clifton, N.J.). 1708: 247-265. PMID 29224148 DOI: 10.1007/978-1-4939-7481-8_13  0.72
2017 He S, Liu Y, Meng L, Sun H, Wang Y, Ji Y, Purushe J, Chen P, Li C, Madzo J, Issa JP, Soboloff J, Reshef R, Moore B, Gattinoni L, et al. Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity. Nature Communications. 8: 2125. PMID 29242551 DOI: 10.1038/s41467-017-02187-8  0.56
2017 Roboz GJ, Kantarjian HM, Yee KWL, Kropf PL, O'Connell CL, Griffiths EA, Stock W, Daver NG, Jabbour E, Ritchie EK, Walsh KJ, Rizzieri D, Lunin SD, Curio T, Chung W, ... ... Issa JJ, et al. Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia. Cancer. PMID 29211308 DOI: 10.1002/cncr.31138  0.44
2017 Maegawa S, Lu Y, Tahara T, Lee JT, Madzo J, Liang S, Jelinek J, Colman RJ, Issa JJ. Caloric restriction delays age-related methylation drift. Nature Communications. 8: 539. PMID 28912502 DOI: 10.1038/s41467-017-00607-3  0.72
2017 Good CR, Madzo J, Patel B, Maegawa S, Engel N, Jelinek J, Issa JJ. A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer. Nucleic Acids Research. PMID 28531272 DOI: 10.1093/nar/gkx435  0.72
2016 Raynal NJ, Da Costa EM, Lee JT, Gharibyan V, Ahmed S, Zhang H, Sato T, Malouf GG, Issa JJ. REPOSITIONING FDA-APPROVED DRUGS IN COMBINATION WITH EPIGENETIC DRUGS TO REPROGRAM COLON CANCER EPIGENOME. Molecular Cancer Therapeutics. PMID 27980103 DOI: 10.1158/1535-7163.MCT-16-0588  0.6
2016 Sato T, Cesaroni M, Chung W, Panjarian S, Tran A, Madzo J, Okamoto Y, Zhang H, Chen X, Jelinek J, Issa JJ. Transcriptional Selectivity of Epigenetic Therapy in Cancer. Cancer Research. PMID 27879268 DOI: 10.1158/0008-5472.CAN-16-0834  0.72
2016 Kleb B, Estécio MR, Zhang J, Tzelepi V, Chung W, Jelinek J, Navone NM, Tahir S, Marquez VE, Issa JP, Maity S, Aparicio A. Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. Epigenetics. 0. PMID 26890396 DOI: 10.1080/15592294.2016.1146851  0.72
2016 Yamazaki J, Taby R, Jelinek J, Raynal NJ, Cesaroni M, Pierce SA, Kornblau SM, Bueso-Ramos CE, Ravandi F, Kantarjian HM, Issa JP. Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia. Journal of the National Cancer Institute. 108. PMID 26568194 DOI: 10.1093/jnci/djv323  0.72
2015 Raynal NJ, Lee JT, Wang Y, Beaudry A, Madireddi P, Garriga J, Malouf GG, Dumont S, Dettman EJ, Gharibyan V, Ahmed S, Chung W, Childers WE, Abou-Gharbia M, Henry RA, ... ... Issa JJ, et al. Targeting calcium signaling induces epigenetic reactivation of tumor suppressor genes in cancer. Cancer Research. PMID 26719529 DOI: 10.1158/0008-5472.CAN-14-2391  0.72
2015 Bouwmeester MC, Ruiter S, Lommelaars T, Sippel J, Hodemaekers HM, van den Brandhof EJ, Pennings JL, Kamstra JH, Jelinek J, Issa JJ, Legler J, van der Ven LT. Zebrafish embryos as a screen for DNA methylation modifications after compound exposure. Toxicology and Applied Pharmacology. 291: 84-96. PMID 26712470 DOI: 10.1016/j.taap.2015.12.012  0.72
2015 Laumet G, Garriga J, Chen SR, Zhang Y, Li DP, Smith TM, Dong Y, Jelinek J, Cesaroni M, Issa JP, Pan HL. G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition. Nature Neuroscience. PMID 26551542 DOI: 10.1038/nn.4165  0.72
2015 Kopetz S, Desai J, Chan E, Hecht JR, O'Dwyer PJ, Maru D, Morris V, Janku F, Dasari A, Chung W, Issa JJ, Gibbs P, James B, Powis G, Nolop KB, et al. Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26460303 DOI: 10.1200/JCO.2015.63.2497  0.32
2015 Jin C, Qin T, Barton MC, Jelinek J, Issa JJ. Minimal Role of Base Excision Repair in TET-Induced Global DNA Demethylation in HEK293T Cells. Epigenetics. 0. PMID 26440216 DOI: 10.1080/15592294.2015.1091145  0.72
2015 Qin T, Si J, Raynal NJ, Wang X, Gharibyan V, Ahmed S, Hu X, Jin C, Lu Y, Shu J, Estecio MR, Jelinek J, Issa JP. Epigenetic synergy between decitabine and platinum derivatives. Clinical Epigenetics. 7: 97. PMID 26366234 DOI: 10.1186/s13148-015-0131-z  0.72
2015 Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Mitchell FT, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar A, ... ... Issa JJ, et al. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prevention Research (Philadelphia, Pa.). PMID 26342026 DOI: 10.1158/1940-6207.CAPR-14-0179  0.72
2015 Issa JP, Roboz G, Rizzieri D, Jabbour E, Stock W, O'Connell C, Yee K, Tibes R, Griffiths EA, Walsh K, Daver N, Chung W, Naim S, Taverna P, Oganesian A, et al. Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study. The Lancet. Oncology. 16: 1099-110. PMID 26296954 DOI: 10.1016/S1470-2045(15)00038-8  0.32
2015 Malouf GG, Tahara T, Paradis V, Fabre M, Guettier C, Yamazaki J, Long H, Lu Y, Raynal NJ, Jelinek J, Mouawad R, Khayat D, Brugières L, Raymond E, Issa JP. Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features. Epigenetics. 10: 872-81. PMID 26224146 DOI: 10.1080/15592294.2015.1076955  0.72
2015 Fujii S, Srivastava V, Hegde A, Kondo Y, Shen L, Hoshino K, Gonzalez Y, Wang J, Sasai K, Ma X, Katayama H, Estecio MR, Hamilton SR, Wistuba I, Issa JP, et al. Regulation of AURKC expression by CpG island methylation in human cancer cells. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 25990457 DOI: 10.1007/s13277-015-3553-5  0.56
2015 Yamazaki J, Jelinek J, Lu Y, Cesaroni M, Madzo J, Neumann F, He R, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Kantarjian HM, Liang S, Estecio MR, Godley LA, ... Issa JP, et al. TET2 mutations affect non-CpG island DNA methylation at enhancers and transcription factor binding sites in chronic myelomonocytic leukemia. Cancer Research. PMID 25972343 DOI: 10.1158/0008-5472.CAN-14-0739  0.72
2014 Xu Y, Zheng X, Yuan Y, Estecio MR, Issa JP, Qiu P, Ji Y, Liang S. BM-SNP: A Bayesian Model for SNP Calling Using High Throughput Sequencing Data. Ieee/Acm Transactions On Computational Biology and Bioinformatics / Ieee, Acm. 11: 1038-44. PMID 26357041 DOI: 10.1109/TCBB.2014.2321407  0.56
2014 Stewart DJ, Nunez MI, Jelinek J, Hong D, Gupta S, Aldaz M, Issa JP, Kurzrock R, Wistuba II. Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples. Clinical Epigenetics. 6: 13. PMID 25024751 DOI: 10.1186/1868-7083-6-13  0.72
2014 Jin C, Lu Y, Jelinek J, Liang S, Estecio MR, Barton MC, Issa JP. TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells. Nucleic Acids Research. 42: 6956-71. PMID 24875481 DOI: 10.1093/nar/gku372  0.72
2014 Pathiraja TN, Nayak SR, Xi Y, Jiang S, Garee JP, Edwards DP, Lee AV, Chen J, Shea MJ, Santen RJ, Gannon F, Kangaspeska S, Jelinek J, Issa JP, Richer JK, et al. Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer. Science Translational Medicine. 6: 229ra41. PMID 24670685 DOI: 10.1126/scitranslmed.3008326  0.72
2014 Maegawa S, Gough SM, Watanabe-Okochi N, Lu Y, Zhang N, Castoro RJ, Estecio MR, Jelinek J, Liang S, Kitamura T, Aplan PD, Issa JP. Age-related epigenetic drift in the pathogenesis of MDS and AML. Genome Research. 24: 580-91. PMID 24414704 DOI: 10.1101/gr.157529.113  0.72
2014 Stewart DJ, Nunez MI, Jelinek J, Hong D, Gupta S, Issa JP, Wistuba II, Kurzrock R. Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors. Clinical Epigenetics. 6: 2. PMID 24401732 DOI: 10.1186/1868-7083-6-2  0.72
2014 Tahara T, Yamamoto E, Suzuki H, Maruyama R, Chung W, Garriga J, Jelinek J, Yamano HO, Sugai T, An B, Shureiqi I, Toyota M, Kondo Y, Estécio MR, Issa JP. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Research. 74: 1311-8. PMID 24385213 DOI: 10.1158/0008-5472.CAN-13-1865  0.72
2014 Tahara T, Yamamoto E, Madireddi P, Suzuki H, Maruyama R, Chung W, Garriga J, Jelinek J, Yamano HO, Sugai T, Kondo Y, Toyota M, Issa JP, Estécio MR. Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators. Gastroenterology. 146: 530-38.e5. PMID 24211491 DOI: 10.1053/j.gastro.2013.10.060  0.72
2013 Malouf GG, Taube JH, Lu Y, Roysarkar T, Panjarian S, Estecio MR, Jelinek J, Yamazaki J, Raynal NJ, Long H, Tahara T, Tinnirello A, Ramachandran P, Zhang XY, Liang S, ... ... Issa JP, et al. Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition. Genome Biology. 14: R144. PMID 24367927 DOI: 10.1186/gb-2013-14-12-r144  0.72
2013 Tahara T, Maegawa S, Chung W, Garriga J, Jelinek J, Estécio MR, Shibata T, Hirata I, Arisawa T, Issa JP. Examination of whole blood DNA methylation as a potential risk marker for gastric cancer. Cancer Prevention Research (Philadelphia, Pa.). 6: 1093-100. PMID 23943784 DOI: 10.1158/1940-6207.CAPR-13-0034  0.72
2013 Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond J, Cortez E, Xie TX, Zhang D, Chung W, Issa JP, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discovery. 3: 770-81. PMID 23619168 DOI: 10.1158/2159-8290.CD-12-0537  0.32
2013 Yamazaki J, Estecio MR, Lu Y, Long H, Malouf GG, Graber D, Huo Y, Ramagli L, Liang S, Kornblau SM, Jelinek J, Issa JP. The epigenome of AML stem and progenitor cells. Epigenetics. 8: 92-104. PMID 23249680 DOI: 10.4161/epi.23243  0.72
2012 Xu Y, Zheng X, Yuan Y, Estecio MR, Issa JP, Ji Y, Liang S. A Bayesian Model for SNP Discovery Based on Next-Generation Sequencing Data. Ieee International Workshop On Genomic Signal Processing and Statistics : [Proceedings]. Ieee International Workshop On Genomic Signal Processing and Statistics. 2012: 42-45. PMID 26726304 DOI: 10.1109/GENSIPS.2012.6507722  0.56
2012 Jelinek J, Liang S, Lu Y, He R, Ramagli LS, Shpall EJ, Estecio MR, Issa JP. Conserved DNA methylation patterns in healthy blood cells and extensive changes in leukemia measured by a new quantitative technique. Epigenetics. 7: 1368-78. PMID 23075513 DOI: 10.4161/epi.22552  0.72
2012 Zhang Y, Shu J, Si J, Shen L, Estecio MR, Issa JP. Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island. Nucleic Acids Research. 40: 7257-68. PMID 22600741 DOI: 10.1093/nar/gks429  0.72
2012 Yamazaki J, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Shen L, Kantarjian HM, Estecio MR, Jelinek J, Godley LA, Issa JP. Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia. Epigenetics. 7: 201-7. PMID 22395470 DOI: 10.4161/epi.7.2.19015  0.72
2012 Raynal NJ, Si J, Taby RF, Gharibyan V, Ahmed S, Jelinek J, Estécio MR, Issa JP. DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Research. 72: 1170-81. PMID 22219169 DOI: 10.1158/0008-5472.CAN-11-3248  0.72
2012 Challen GA, Sun D, Jeong M, Luo M, Jelinek J, Berg JS, Bock C, Vasanthakumar A, Gu H, Xi Y, Liang S, Lu Y, Darlington GJ, Meissner A, Issa JP, et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nature Genetics. 44: 23-31. PMID 22138693 DOI: 10.1038/ng.1009  0.72
2011 Konishi K, Watanabe Y, Shen L, Guo Y, Castoro RJ, Kondo K, Chung W, Ahmed S, Jelinek J, Boumber YA, Estecio MR, Maegawa S, Kondo Y, Itoh F, Imawari M, ... ... Issa JP, et al. DNA methylation profiles of primary colorectal carcinoma and matched liver metastasis. Plos One. 6: e27889. PMID 22132162 DOI: 10.1371/journal.pone.0027889  0.72
2011 Qin T, Castoro R, El Ahdab S, Jelinek J, Wang X, Si J, Shu J, He R, Zhang N, Chung W, Kantarjian HM, Issa JP. Mechanisms of resistance to decitabine in the myelodysplastic syndrome. Plos One. 6: e23372. PMID 21858090 DOI: 10.1371/journal.pone.0023372  0.72
2011 Watanabe Y, Castoro RJ, Kim HS, North B, Oikawa R, Hiraishi T, Ahmed SS, Chung W, Cho MY, Toyota M, Itoh F, Estecio MR, Shen L, Jelinek J, Issa JP. Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancer. Plos One. 6: e23320. PMID 21853109 DOI: 10.1371/journal.pone.0023320  0.72
2011 Jelinek J, Gharibyan V, Estecio MR, Kondo K, He R, Chung W, Lu Y, Zhang N, Liang S, Kantarjian HM, Cortes JE, Issa JP. Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. Plos One. 6: e22110. PMID 21760961 DOI: 10.1371/journal.pone.0022110  0.72
2011 Chung W, Bondaruk J, Jelinek J, Lotan Y, Liang S, Czerniak B, Issa JP. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1483-91. PMID 21586619 DOI: 10.1158/1055-9965.EPI-11-0067  0.72
2011 Pathiraja TN, Shetty PB, Jelinek J, He R, Hartmaier R, Margossian AL, Hilsenbeck SG, Issa JP, Oesterreich S. Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4177-86. PMID 21459801 DOI: 10.1158/1078-0432.CCR-10-2950  0.72
2011 Cogdell D, Chung W, Liu Y, McDonald JM, Aldape K, Issa JP, Fuller GN, Zhang W. Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with glioma. Chinese Journal of Cancer. 30: 247-53. PMID 21439246  0.32
2010 Wallace K, Grau MV, Levine AJ, Shen L, Hamdan R, Chen X, Gui J, Haile RW, Barry EL, Ahnen D, McKeown-Eyssen G, Baron JA, Issa JP. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prevention Research (Philadelphia, Pa.). 3: 1552-64. PMID 21149331 DOI: 10.1158/1940-6207.CAPR-10-0047  0.56
2010 Estécio MR, Gallegos J, Vallot C, Castoro RJ, Chung W, Maegawa S, Oki Y, Kondo Y, Jelinek J, Shen L, Hartung H, Aplan PD, Czerniak BA, Liang S, Issa JP. Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Research. 20: 1369-82. PMID 20716667 DOI: 10.1101/gr.107318.110  0.72
2010 Si J, Boumber YA, Shu J, Qin T, Ahmed S, He R, Jelinek J, Issa JP. Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Research. 70: 6968-77. PMID 20713525 DOI: 10.1158/0008-5472.CAN-09-4474  0.72
2010 Kwabi-Addo B, Wang S, Chung W, Jelinek J, Patierno SR, Wang BD, Andrawis R, Lee NH, Apprey V, Issa JP, Ittmann M. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3539-47. PMID 20606036 DOI: 10.1158/1078-0432.CCR-09-3342  0.72
2010 Oki Y, Issa JPJ. Epigenetic mechanisms in AML - A target for therapy Cancer Treatment and Research. 145: 19-40. PMID 20306243 DOI: 10.1007/978-0-387-69259-3_2  0.32
2010 An B, Kondo Y, Okamoto Y, Shinjo K, Kanemitsu Y, Komori K, Hirai T, Sawaki A, Tajika M, Nakamura T, Yamao K, Yatabe Y, Fujii M, Murakami H, Osada H, ... ... Issa JP, et al. Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers. International Journal of Cancer. Journal International Du Cancer. 127: 2095-105. PMID 20131317 DOI: 10.1002/ijc.25225  0.56
2010 Maegawa S, Hinkal G, Kim HS, Shen L, Zhang L, Zhang J, Zhang N, Liang S, Donehower LA, Issa JP. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Research. 20: 332-40. PMID 20107151 DOI: 10.1101/gr.096826.109  0.56
2010 Shen L, Kantarjian H, Guo Y, Lin E, Shan J, Huang X, Berry D, Ahmed S, Zhu W, Pierce S, Kondo Y, Oki Y, Jelinek J, Saba H, Estey E, ... Issa JP, et al. DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 605-13. PMID 20038729 DOI: 10.1200/JCO.2009.23.4781  0.72
2010 Suzuki H, Igarashi S, Nojima M, Maruyama R, Yamamoto E, Kai M, Akashi H, Watanabe Y, Yamamoto H, Sasaki Y, Itoh F, Imai K, Sugai T, Shen L, Issa JPJ, et al. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype Carcinogenesis. 31: 342-349. PMID 19638426 DOI: 10.1093/carcin/bgp179  0.56
2009 Liang S, Lu Y, Jelinek J, Estecio M, Li H, Issa JP. Analysis of epigenetic modifications by next generation sequencing. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2009: 6730. PMID 19963934 DOI: 10.1109/IEMBS.2009.5332853  0.72
2009 Goto Y, Shinjo K, Kondo Y, Shen L, Toyota M, Suzuki H, Gao W, An B, Fujii M, Murakami H, Osada H, Taniguchi T, Usami N, Kondo M, Hasegawa Y, ... ... Issa JP, et al. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma. Cancer Research. 69: 9073-82. PMID 19887624 DOI: 10.1158/0008-5472.CAN-09-1595  0.56
2009 Konishi K, Shen L, Jelinek J, Watanabe Y, Ahmed S, Kaneko K, Kogo M, Takano T, Imawari M, Hamilton SR, Issa JP. Concordant DNA methylation in synchronous colorectal carcinomas. Cancer Prevention Research (Philadelphia, Pa.). 2: 814-22. PMID 19737982 DOI: 10.1158/1940-6207.CAPR-09-0054  0.72
2009 Stewart DJ, Issa JP, Kurzrock R, Nunez MI, Jelinek J, Hong D, Oki Y, Guo Z, Gupta S, Wistuba II. Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3881-8. PMID 19470736 DOI: 10.1158/1078-0432.CCR-08-2196  0.72
2009 Tellez CS, Shen L, Estécio MR, Jelinek J, Gershenwald JE, Issa JP. CpG island methylation profiling in human melanoma cell lines. Melanoma Research. 19: 146-55. PMID 19441164  0.72
2009 Watanabe Y, Kim HS, Castoro RJ, Chung W, Estecio MR, Kondo K, Guo Y, Ahmed SS, Toyota M, Itoh F, Suk KT, Cho MY, Shen L, Jelinek J, Issa JP. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology. 136: 2149-58. PMID 19375421 DOI: 10.1053/j.gastro.2009.02.085  0.72
2009 Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B, Lim R, Tewari M, Gartler SM, Issa JP, Pavlidis P, et al. Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell. 4: 359-69. PMID 19341625 DOI: 10.1016/j.stem.2009.03.001  0.56
2009 Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, Hamdan R, Chen X, Bresalier RS, McKeown-Eyssen G, Haile RW, Baron JA, Issa JP. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1041-9. PMID 19336559 DOI: 10.1158/1055-9965.EPI-08-0926  0.56
2009 Kim MJ, White-Cross JA, Shen L, Issa JP, Rashid A. Hypomethylation of long interspersed nuclear element-1 in hepatocellular carcinomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 22: 442-9. PMID 19136926 DOI: 10.1038/modpathol.2008.203  0.56
2009 Qin T, Jelinek J, Si J, Shu J, Issa JP. Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines. Blood. 113: 659-67. PMID 18931345 DOI: 10.1182/blood-2008-02-140038  0.72
2008 Boumber YA, Kondo Y, Chen X, Shen L, Guo Y, Tellez C, Estécio MR, Ahmed S, Issa JP. An Sp1/Sp3 binding polymorphism confers methylation protection. Plos Genetics. 4: e1000162. PMID 18725933 DOI: 10.1371/journal.pgen.1000162  0.6
2008 Gao W, Kondo Y, Shen L, Shimizu Y, Sano T, Yamao K, Natsume A, Goto Y, Ito M, Murakami H, Osada H, Zhang J, Issa JP, Sekido Y. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis. 29: 1901-10. PMID 18632756 DOI: 10.1093/carcin/bgn170  0.56
2007 Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, Shu J, Chen X, Waterland RA, Issa JP. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. Plos Genetics. 3: 2023-36. PMID 17967063 DOI: 10.1371/journal.pgen.0030181  0.72
2007 Qin T, Youssef EM, Jelinek J, Chen R, Yang AS, Garcia-Manero G, Issa JP. Effect of cytarabine and decitabine in combination in human leukemic cell lines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4225-32. PMID 17634552 DOI: 10.1158/1078-0432.CCR-06-2762  0.72
2007 Boumber YA, Kondo Y, Chen X, Shen L, Gharibyan V, Konishi K, Estey E, Kantarjian H, Garcia-Manero G, Issa JP. RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis. Cancer Research. 67: 1997-2005. PMID 17332327 DOI: 10.1158/0008-5472.CAN-06-3093  0.6
2006 Shu J, Jelinek J, Chang H, Shen L, Qin T, Chung W, Oki Y, Issa JP. Silencing of bidirectional promoters by DNA methylation in tumorigenesis. Cancer Research. 66: 5077-84. PMID 16707430 DOI: 10.1158/0008-5472.CAN-05-2629  0.72
Show low-probability matches.